New Two-Pronged attack tested against tough head and neck cancers
NCT ID NCT06959108
Summary
This study aims to see if using two newer drugs together before standard chemoradiation works better than using one of those drugs alone for people with advanced head and neck cancer. About 106 participants will be randomly assigned to receive either the single drug or the two-drug combination as an initial 'induction' treatment. The main goal is to compare how many patients' tumors shrink significantly with each approach before they move on to standard chemoradiation therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.